ArticleFrontiers in immunology2026

Integrative omics and experimental validation reveal METTL17 and SLC27A1 as biomarkers and potential therapeutic targets in chronic kidney disease.

Shiyun Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.